Home › Degenerative Nerve Diseases › New York
Degenerative Nerve Diseases clinical trials in New York
4 studies for Degenerative Nerve Diseases are looking for participants at sites in New York.
Cities in New York
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Clinical Site, New York
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Sep 30, 2026 · NCT06887192A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Sep 11, 2026 · NCT07804615Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Recruiting
Ages 50 and older · All sexes · Updated Aug 27, 2026 · NCT06993142PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
- University of Rochester, Rochester
RecruitingObservational studyHealthy volunteers welcome
Ages 30 and older · All sexes · Updated Jul 27, 2026 · NCT04477785From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.